Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 12, 2003

View Archived Issues

NaPro receives SBIR grant for work in Duchenne muscular dystrophy

Vion enters research and option agreement for novel anticancer compounds

Disease stabilization in phase II multiple myeloma study of Panzem

Human challenge study of FluINsure confirms efficacy of vaccine

Safety and clinical efficacy of GW-572016 in advanced breast cancer

BMS-247550 in metastatic breast cancer

Palifermin improves quality of life in cancer patients with oral mucositis

New PARP inhibitors described by KuDOS and Maybridge scientists

GSK patent covers novel p38 MAP kinase inhibitors and their use

Schering AG researchers claim new PLK inhibitors for cancer and other uses

New opioid receptors modulators prepared and tested at Janssen

Merck KGaA claims novel semicarbazide-based factor Xa and/or factor VIIa inhibitors

Series of mGluR antagonists described by Euroceltique researchers in a recent patent

SC-12267 advanced into phase I for rheumatoid arthritis

Celmed BioSciences and NIH to test Theralux for GvHD

Grant supports matriptase inhibitor development at Curacyte

New preclinical and phase I data presented for CYC-202

Genta completes NDA submission for Genasense for malignant melanoma

Continued positive interim data from phase II extension study of Alzhemed

Immediate-release indiplon shows promise for MOTN administration

Bayer acquires Fosrenol rights in Japan

Belgian phase I trial evaluates tgAAC09

TGN-255 shows desired anticoagulant pharmacodynamic properties in phase I study

ICL-670 in beta-thalassemia and associated transfusional iron overload

Safety profile of sustained-release bupropion in epilepsy patients

Clinical benefits of pregabalin in epilepsy

Antiangiogenic PKC-beta inhibitor identified at J&J

Nonhypercalcemic vitamin D3 analogue HY-11 shows promising antileukemic activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...